CeriBell Balance Sheet
NASDAQ: CBLLHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CeriBell financial position
At the end of fiscal 2025, CeriBell reported total assets of $195.8 million, down 13.1% from a year earlier against total liabilities of $40.5 million. Shareholders' equity stood at $155.3 million, or 79.3% of assets. The company held $40.5 million in cash and equivalents against $19.8 million of debt, a net cash position of $20.7 million.
The current ratio (current assets divided by current liabilities) was 9.73, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.13.
Summary generated from market data by MetaCap's automated system. Methodology
CeriBell balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 |
|---|---|---|---|
| Cash & Equivalents | 40.48M | 194.37M | 34.49M |
| Short-Term Investments | 118.78M | — | — |
| Receivables | 15.05M | 10.88M | 7.96M |
| Inventory | 7.29M | 6.94M | 5.87M |
| Total Current Assets | 186.72M | 217.27M | 51.96M |
| Property, Plant & Equipment | 2.03M | 2.31M | 1.58M |
| Total Assets | 195.80M | 225.41M | 58.92M |
| Accounts Payable | 2.84M | 1.14M | 732.00K |
| Total Current Liabilities | 19.19M | 12.99M | 21.60M |
| Long-Term Debt | 19.81M | 19.56M | — |
| Total Liabilities | 40.47M | 34.25M | 23.76M |
| Shareholders' Equity | 155.34M | 191.16M | -112.25M |
| Retained Earnings | -220.36M | -166.94M | -126.49M |
| Total Debt | 19.81M | 19.56M | — |
| Net Cash (Debt) | 139.45M | 174.81M | 34.49M |
| Shares Outstanding | 37.49M | 35.85M | 5.43M |
This table shows 3 annual periods of CeriBell's balance sheet, from FY 2025 back to FY 2023, across 16 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow CBLL's reporting calendar. What is a balance sheet?